These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11709874)

  • 21. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P; Korenman S; Davis S
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Weight of obesity in (pre)type 2 diabetes in children and adolescents: how and when to screen for?].
    Mouraux T; Dorchy H
    Arch Pediatr; 2005 Dec; 12(12):1779-84. PubMed ID: 16289780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Associated risk factors of fatty liver in the patients with type 2 diabetes mellitus].
    Chen QK; Chen HY; Wang LY; Zeng ZY; Zhou XD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):414-6. PubMed ID: 15268806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central obesity and risk for type 2 diabetes in Maori, Pacific, and European young men in New Zealand.
    Rush EC; Plank LD; Mitchelson E; Laulu MS
    Food Nutr Bull; 2002 Sep; 23(3 Suppl):82-6. PubMed ID: 12362820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of diabetes in cardiac diseases].
    Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P; Raingeard I; Renard E; Bringer J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interconnection between insulin resistance and lipid metabolism disorders in obese patients].
    Ageeva VV; Krasil'nikova EI; Zubina IM; Shliakhto EV
    Ter Arkh; 2002; 74(10):12-5. PubMed ID: 12469622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
    Faur L; Motocu M; Moldovan C; Onaca M; Muţiu G
    Rom J Morphol Embryol; 2005; 46(4):307-9. PubMed ID: 16688368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism.
    Sowers JR
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S39-47. PubMed ID: 16989076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National Maori Diabetes Organisation.
    N Z Med J; 1994 May; 107(978):208. PubMed ID: 8196871
    [No Abstract]   [Full Text] [Related]  

  • 34. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of doxazosin on insulin resistance in hypertensive patients with obesity.
    Ueshiba H; Miyachi Y
    Horm Metab Res; 2003 Sep; 35(9):532-6. PubMed ID: 14517769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin therapy in patients with myocardial ischemia and type II diabetes before and after myocardial revascularization].
    Mashkova OV; Belov IuV; Ametov AS; Kalina NV
    Khirurgiia (Mosk); 2004; (7):36-7. PubMed ID: 15340327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Type 1 and type 2 diabetes: molecular parallels].
    Donath MY
    Journ Annu Diabetol Hotel Dieu; 2004; ():11-7. PubMed ID: 15259301
    [No Abstract]   [Full Text] [Related]  

  • 40. The metabolic syndrome X.
    Hansen BC
    Ann N Y Acad Sci; 1999 Nov; 892():1-24. PubMed ID: 10842649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.